Humanin Therapy
Humanin is a 24-amino acid mitochondrial-derived peptide first discovered in 2001 from a cDNA library of the brain of a patient with Alzheimer's disease. It was the first member of the now-expanding class of mitochondrial-derived peptides to be identified. Humanin is encoded in the 16S ribosomal RNA gene of the mitochondrial genome and has been found in multiple tissues throughout the body, with circulating levels declining significantly with age. Its discovery opened an entirely new chapter in our understanding of mitochondrial signaling and its role in neuroprotection and longevity.
How Humanin Works
Humanin exerts its protective effects through several receptor-mediated mechanisms. It binds to and activates the FPRL1 receptor (formyl peptide receptor-like 1) and the CNTFR/WSX-1/gp130 trimeric receptor complex, triggering intracellular signaling cascades that promote cell survival. These pathways include activation of STAT3 signaling, which suppresses apoptosis (programmed cell death) and promotes cellular resilience. Humanin also inhibits the pro-apoptotic protein Bax, preventing its translocation to mitochondria and blocking the mitochondrial death pathway. Additionally, it has been shown to improve insulin sensitivity through IGFBP-3 interaction and to reduce oxidative stress by supporting mitochondrial membrane integrity.
Potential Benefits of Humanin
- May support neuroprotective processes based on extensive preclinical research
- Has been associated with enhanced cellular survival under stress conditions
- Commonly sought for its potential to protect against age-related cognitive decline
- May promote improved insulin sensitivity and metabolic resilience
- Patients often seek it for comprehensive longevity protocols
- Has been linked to cardioprotective effects in preclinical models
- May support mitochondrial function and reduce oxidative damage
Conditions Commonly Associated With Humanin
People commonly seek Humanin for support with the following concerns:
Related treatment guides:
Who Commonly Seeks Humanin?
Humanin is sought by longevity-focused individuals who are deeply engaged with the latest research in mitochondrial biology and aging science. Patients with a family history of neurodegenerative conditions who wish to proactively support brain health are common candidates. It is also sought by those implementing comprehensive anti-aging protocols that target multiple hallmarks of aging simultaneously.
Administration & Protocols
Humanin is typically administered via subcutaneous injection. Protocols are still evolving as the peptide is relatively new to clinical practice. Some practitioners administer it daily while others use several times weekly. Due to its newer status in clinical settings, protocols are highly provider-dependent and often incorporate biomarker monitoring to assess response.
For Patients
Looking for Humanin therapy? Get matched with a provider near you.
Humanin Cost & Pricing
The cost of Humanin therapy varies depending on your provider, location, dosing protocol, and treatment duration. For a detailed pricing breakdown, visit our dedicated cost page.
View Humanin pricing detailsFrequently Asked Questions About Humanin
Related Peptides
MOTS-c
MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a mitochondrial-derived peptide consisting of 1…
Epithalon
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the naturally occurring epithal…
NAD+
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme found in every living cell, playing a central role in ce…
Cerebrolysin
Cerebrolysin is a unique peptide preparation consisting of low-molecular-weight neuropeptides and free amino acids deriv…
Compare Humanin
See how Humanin compares to similar peptides side-by-side.
Find Humanin Providers by State
Browse Humanin therapy providers in your state for location-specific information and clinic listings.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Peptide therapies should only be administered by licensed healthcare providers. Always consult with a qualified healthcare professional before starting any new treatment. PeptideLeads is a marketing agency and does not provide medical services.